Skip to main content
Clinical Trials/ISRCTN17573492
ISRCTN17573492
Completed
未知

A double-blind randomised placebo-controlled feasibility study to assess the impact of octreotide infusion during liver transplantation on post-operative renal failure.

niversity College London0 sites30 target enrollmentOctober 5, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Perioperative bleeding, liver transplant
Sponsor
niversity College London
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2021
End Date
October 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18 years
  • 2\. Undergoing primary liver transplantation of a whole or partial liver graft from a cardiac or brain dead donor
  • 3\. Provision of written informed consent

Exclusion Criteria

  • 1\. Previous solid organ transplant
  • 2\. Acute liver failure
  • 3\. Fulminant hepatic failure
  • 4\. Patients receiving a living donor liver graft
  • 5\. Patients currently admitted to ICU prior to transplantation
  • 6\. Requirement of haemodialysis or Continuous Veno\-Venous Hemofiltration (CVVHF) pre\-operatively
  • 7\. Known allergy or adverse reaction to octreotide
  • 8\. Pre\-operative decision to use intra\-operative CVVHF
  • 9\. A positive pregnancy test

Outcomes

Primary Outcomes

Not specified

Similar Trials